The historical rank and industry rank for Quoin Pharmaceuticals's Equity-to-Asset or its related term are showing as below:
QNRX'
s Equity-to-Asset Range Over the Past 10 Years
Min: -8.82 Med: 0.47 Max: 0.59
Current: 0.57
During the past 5 years, the highest Equity to Asset Ratio of Quoin Pharmaceuticals was 0.59. The lowest was -8.82. And the median was 0.47.
QNRX's Equity-to-Asset is ranked worse than 58.55% of 1556
companies
in the Biotechnology industry
Industry Median: 0.67
vs QNRX: 0.57
Quoin Pharmaceuticals Equity-to-Asset Historical Data
The historical data trend for Quoin Pharmaceuticals's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Quoin Pharmaceuticals's Equity-to-Asset
For the Biotechnology subindustry, Quoin Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quoin Pharmaceuticals's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Quoin Pharmaceuticals's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Quoin Pharmaceuticals's Equity-to-Asset falls into.
Quoin Pharmaceuticals Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Quoin Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Quoin Pharmaceuticals Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Quoin Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Quoin Pharmaceuticals (Quoin Pharmaceuticals) Business Description
Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
QNRX has been successfully added to your 